Persistent bone marrow and imaging MRD negativity may guide the duration of lenalidomide maintenance ASCT in patients with multiple myeloma
Panagiotis Malandrakis,Ioannis Ntanasis-Stathopoulos,Ioannis Kostopoulos,Maria Gavriatopoulou,Foteini Theodorakakou,Despina Fotiou,Magdalini Migkou,Maria Roussou, Vassiliki Spiliopoulou,Evangelos Eleutherakis-Papaiakovou,Efstathios Kastritis,Ourania Tsitsilonis,Meletios Dimopoulos,Evangelos Terpos CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
AI 理解论文
溯源树
样例
